Drug injecting and HIV infection: global dimensions and local responses
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
London [u.a.]
UCL Press
1998
|
Ausgabe: | 1. publ. |
Schriftenreihe: | Social aspects of AIDS
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XVII, 294 S. |
ISBN: | 1857288246 1857288254 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV012533677 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 990429s1998 |||| 00||| eng d | ||
020 | |a 1857288246 |9 1-85728-824-6 | ||
020 | |a 1857288254 |9 1-85728-825-4 | ||
035 | |a (OCoLC)39667238 | ||
035 | |a (DE-599)BVBBV012533677 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 | ||
050 | 0 | |a RA644.A25 | |
082 | 0 | |a 616.97/9205 |2 21 | |
245 | 1 | 0 | |a Drug injecting and HIV infection |b global dimensions and local responses |c ed. by Gerry V. Stimson ... |
250 | |a 1. publ. | ||
264 | 1 | |a London [u.a.] |b UCL Press |c 1998 | |
300 | |a XVII, 294 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Social aspects of AIDS | |
650 | 2 | |a Infections à VIH - transmission | |
650 | 2 | |a Toxicomanie intraveineuse | |
650 | 2 | |a Échange aiguille | |
650 | 4 | |a AIDS (Disease) |x Prevention | |
650 | 4 | |a HIV Infections |x prevention & control | |
650 | 4 | |a HIV Infections |x transmission | |
650 | 4 | |a Intravenous drug abuse | |
650 | 4 | |a Needle Sharing |x adverse effects | |
650 | 4 | |a Substance Abuse, Intravenous |x complications | |
650 | 4 | |a Substance Abuse, Intravenous |x prevention & control | |
650 | 0 | 7 | |a Epidemiologie |0 (DE-588)4015016-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a HIV-Infektion |0 (DE-588)4203852-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |D s |
689 | 0 | 1 | |a HIV-Infektion |0 (DE-588)4203852-2 |D s |
689 | 0 | 2 | |a Epidemiologie |0 (DE-588)4015016-1 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |D s |
689 | 1 | 1 | |a HIV-Infektion |0 (DE-588)4203852-2 |D s |
689 | 1 | 2 | |a Prävention |0 (DE-588)4076308-0 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Stimson, Gerry V. |e Sonstige |4 oth | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008509925&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-008509925 |
Datensatz im Suchindex
_version_ | 1804127180051972096 |
---|---|
adam_text | Contents
List of Figures vii
List of Tables viii
Foreword xi
Series Editor s Preface xv
Acknowledgments xvii
Chapter 1 Global Perspectives on Drug Injecting 1
Gerry V. Stimson and Kachit Choopanya
Chapter 2 The Social Context of Injectors Risk Behaviour 22
Neil McKeganey, Samuel R. Friedman and Fabio Mesquita
Chapter 3 Health and Social Consequences of Injecting Drug Use 42
Martin C. Donoghoe and Alex Wodak
Chapter 4 Drug Injecting and HIV 1 Infection:
Major Findings from the Multi City Study 58
Meni Malliori, Maria Victoria Zunzunegui, Angeles Rodriguez
Arenas and David Goldberg
Chapter 5 New Injectors and HIV 1 Risk 76
Samuel R. Friedman, Patricia Friedmann, Paulo Telles, Francisco
Bastos, Regina Bueno, Fabio Mesquita and Don C. Des Jarlais
Chapter 6 The Structure of Stable Seroprevalence HIV 1 Epidemics
among Injecting Drug Users 91
Don C. Des Jarlais, Kachit Choopanya, Peggy Millson, Patricia
Friedmann and Samuel R. Friedman
Chapter 7 Mobility and the Diffusion of Drug Injecting and HIV
Infection 101
Martin Frischer
v
Contents
Chapter 8 Modelling the HIV 1 and AIDS Epidemic among Drug
Injectors 115
Carlo A. Perucci, Damiano Abeni, Massimo Area, Marina Davoli
and Andrea Pugliese
Chapter 9 Drug Injecting and Sexual Safety: Cross national Compari¬
sons among Cocaine and Opioid Injectors 130
Tim Rhodes, Ted Myers, Regina Bueno, Peggy Millson and
Gillian Hunter
Chapter 10 Cities Responding to HIV 1 Epidemics among Injecting
Drug Users 149
Francisco Bastos, Gerry V. Stimson, Paulo Telles and
Christovam Barcellos
Chapter 11 Prison and HIV 1 Infection among Drug Injectors 168
Damiano Abeni, Carlo A. Perucci, Kate Dolan and
Massimo Sangalli
Chapter 12 Preventing Epidemics of HIV 1 among Injecting Drug
Users 183
Don C. Desjarlais, Holly Hagan, Samuel R. Friedman,
Patricia Friedmann, David Goldberg, Martin Frischer, Steven Green,
Kerstin Tunving, Bengt Ljungberg, Alex Wodak, Michael Ross,
David Purchase, Peggy Millson and Ted Myers
Chapter 13 Overview: Policies and Interventions to Stem HIV 1 Epide¬
mics associated with Injecting Drug Use 201
Andrew L. Ball
Appendix 1 Methodology of the World Health Organization Multi City
Study on Drug Injecting and Risk of HIV Infection 233
David Goldberg
Appendix 2 City Epidemics and Contexts 243
Fabio Mesquita, Paulo Telles, Francisco Bastos and
Gerry V. Stimson
Appendix 3 Contributors and Collaborating Agencies in the World
Health Organization Multi City Study on Drug Injecting
and Risk of HIV Infection 277
Contributors 280
Index 283
vi
List of Figures
1.1 Countries and territories with injecting drug use and HIV
infection among IDUs, by July 1996 2
7.1 The spread of heroin use among 58 people living in Crawley,
England, during 1967 103
8.1 Incident cases of HIV 1 infection, by group 123
8.2 Prevalent cases of HIV 1 infection, by group 123
8.3 Predicted effect of a harm reduction programme on HIV 1
prevalence among IDUs 125
8.4 Predicted effect of a harm reduction programme on HIV 1
prevalence among NDIHs 126
9.1 Key findings on IDUs sexual risk behaviour 134
9.2 Cocaine and heroin injection in previous 6 months 138
10.1 AIDS incidence rates in Brazilian states, 1987 158
10.2 AIDS incidence rates in Brazilian states, 1992 159
10.3 AIDS incidence rates related to drug injecting in Brazilian main
cities, 1983 to 1992 160
10.4 AIDS incidence rates related to homo and bisexual intercourse in
Brazilian main cities, 1983 to 1992 161
13.1 Hierarchy of harm reduction choices 204
vii
List of Tables
4.1 Gender, age at time of interview, normal place of residence (in
the city sampled) 59
4.2 Years of full time education completed, main source of income 60
4.3 Marital status, living circumstances, children, prison 61
4.4 Age at first injection, number of years injecting, frequency of
injection 63
4.5 Any injection of heroin, cocaine, heroin and cocaine, methadone,
amphetamine, tranquillizers, barbiturates, during previous six
months 64
4.6 Percentage of injectors using needles/syringes received from
someone else; number of people n/s were received from;
percentage of injectors who passed on n/s; number of people they
passed n/s onto 65
4.7 Percentage of injectors who always cleaned used needles/
syringes; methods used for cleaning n/s; where clean n/s were
obtained from 66
4.8 Frequency of sexual intercourse (vaginal, anal, oral); frequency
of vaginal intercourse with primary and with casual partners 68
4.9 Anal intercourse reported with primary and casual partners;
anal or vaginal intercourse reported with more than two primary
partners or more than two casual partners 69
4.10 Frequency of condom use with primary and casual partners 70
4.11 Percentage of primary and casual partners who had ever injected
drugs; percentage of females who had been given money, goods
or drugs for sex; percentage of men who had sex with men 71
4.12 Percentage who talk frequently with drug using friends, sexual
partners, family members about AIDS; belief that a person can
have the AIDS virus and look well; perception of numbers of
people who have the AIDS virus that become seriously ill; any
behaviour change to avoid catching the virus (since first hearing
of AIDS) 73
4.13 Percentage who had ever been tested for HIV; percentage who
self reported as positive; percentage who tested positive 74
5.1 New and old injectors, by site and total sample 78
viii
List of Tables
5.2 Percentage of new injectors, by gender, by site and by total
sample 79
5.3 Percentage HIV seropositive of new injectors and old injectors,
by site and by total sample 79
5.4 Percentage HIV seropositive by gender among new injectors, by
site and by total sample 81
5.5 Percentage who engaged in risk behaviours in prior six months
for new injectors and older injectors, by city seroprevalence 83
6.1 Number and percentage of persons reporting behaviour change
when asked Since you first heard of AIDS, have you done
anything to avoid catching the virus yourself? 94
6.2 Number and percentage of injecting drug users who reported
injecting with equipment previously used by someone else
( sharing ) during the six months prior to interview 96
6.3 Seroconversion analysis based on previous self reported negative
HIV 1 test and positive HIV 1 test when surveyed 97
7.1 Factors influencing migration of Italian drug injectors to
London 105
7.2 Proportion of respondents in the WHO Study reporting
injecting, and sharing needles and syringes, outside study city in
previous two years 110
7.3 Injecting, and sharing needles and syringes, outside study city,
by risk behaviour and selected attributes 110
7.4 Proportion HIV 1 positive by injecting and equipment sharing
outside of study area in the previous two years 111
8.1 Behavioural parameters of IDUs in Rome estimated from the
WHO Multi City Study results 121
8.2 Predicted new HIV 1 infections in 1991 and 1992 by group and
transmission route 124
9.1 Penetrative sex with opposite sex partners in last 6 months 139
9.2 Condom use with opposite sex partners in last 6 months 141
10.1 Attitudes of the general public towards IDUs, and engagement
of IDUs in preventive strategies 150
10.2 Implementation of needle exchange programmes and bleach
distribution 152
11.1 Frequency of imprisonment among participants in the WHO
Multi City Study 175
11.2 Prevalence of HIV 1 infection among IDUs who underwent
HIV 1 testing in the WHO Multi City Study, by frequency of
imprisonment 176
11.3 Factors associated with HIV 1 positivity by injecting drug users,
Rome 1990 2 177
12.1 Characteristics of the injecting drug user populations in five
cities with stable low HIV seroprevalence 186
ix
List of Tables
12.2 Injecting drug users in five cities with stable low HIV
seroprevalence 187
12.3 Selected demographic characteristics and HIV related risk
behaviours of IDUs in five cities 190
12.4 Prevention components and injecting drug user responses to
AIDS in five cities with stable low HIV seroprevalence 191
12.5 Case control analysis of prevention components and stable low
HIV seroprevalence in 22 cities 195
A 1.1 Recruitment sites 239
A1.2 Sample size in each city, and proportion of sample recruited in
and out of treatment 240
x
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV012533677 |
callnumber-first | R - Medicine |
callnumber-label | RA644 |
callnumber-raw | RA644.A25 |
callnumber-search | RA644.A25 |
callnumber-sort | RA 3644 A25 |
callnumber-subject | RA - Public Medicine |
ctrlnum | (OCoLC)39667238 (DE-599)BVBBV012533677 |
dewey-full | 616.97/9205 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.97/9205 |
dewey-search | 616.97/9205 |
dewey-sort | 3616.97 49205 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
edition | 1. publ. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02323nam a2200601 c 4500</leader><controlfield tag="001">BV012533677</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">990429s1998 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1857288246</subfield><subfield code="9">1-85728-824-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1857288254</subfield><subfield code="9">1-85728-825-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)39667238</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012533677</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA644.A25</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.97/9205</subfield><subfield code="2">21</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug injecting and HIV infection</subfield><subfield code="b">global dimensions and local responses</subfield><subfield code="c">ed. by Gerry V. Stimson ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">UCL Press</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 294 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Social aspects of AIDS</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Infections à VIH - transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Toxicomanie intraveineuse</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Échange aiguille</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AIDS (Disease)</subfield><subfield code="x">Prevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Infections</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Infections</subfield><subfield code="x">transmission</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Intravenous drug abuse</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Needle Sharing</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance Abuse, Intravenous</subfield><subfield code="x">complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance Abuse, Intravenous</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Epidemiologie</subfield><subfield code="0">(DE-588)4015016-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">HIV-Infektion</subfield><subfield code="0">(DE-588)4203852-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">HIV-Infektion</subfield><subfield code="0">(DE-588)4203852-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Epidemiologie</subfield><subfield code="0">(DE-588)4015016-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">HIV-Infektion</subfield><subfield code="0">(DE-588)4203852-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stimson, Gerry V.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008509925&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008509925</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV012533677 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T18:29:15Z |
institution | BVB |
isbn | 1857288246 1857288254 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008509925 |
oclc_num | 39667238 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | XVII, 294 S. |
publishDate | 1998 |
publishDateSearch | 1998 |
publishDateSort | 1998 |
publisher | UCL Press |
record_format | marc |
series2 | Social aspects of AIDS |
spelling | Drug injecting and HIV infection global dimensions and local responses ed. by Gerry V. Stimson ... 1. publ. London [u.a.] UCL Press 1998 XVII, 294 S. txt rdacontent n rdamedia nc rdacarrier Social aspects of AIDS Infections à VIH - transmission Toxicomanie intraveineuse Échange aiguille AIDS (Disease) Prevention HIV Infections prevention & control HIV Infections transmission Intravenous drug abuse Needle Sharing adverse effects Substance Abuse, Intravenous complications Substance Abuse, Intravenous prevention & control Epidemiologie (DE-588)4015016-1 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf HIV-Infektion (DE-588)4203852-2 gnd rswk-swf Drogenabhängigkeit (DE-588)4138597-4 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Drogenabhängigkeit (DE-588)4138597-4 s HIV-Infektion (DE-588)4203852-2 s Epidemiologie (DE-588)4015016-1 s DE-604 Prävention (DE-588)4076308-0 s Stimson, Gerry V. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008509925&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Drug injecting and HIV infection global dimensions and local responses Infections à VIH - transmission Toxicomanie intraveineuse Échange aiguille AIDS (Disease) Prevention HIV Infections prevention & control HIV Infections transmission Intravenous drug abuse Needle Sharing adverse effects Substance Abuse, Intravenous complications Substance Abuse, Intravenous prevention & control Epidemiologie (DE-588)4015016-1 gnd Prävention (DE-588)4076308-0 gnd HIV-Infektion (DE-588)4203852-2 gnd Drogenabhängigkeit (DE-588)4138597-4 gnd |
subject_GND | (DE-588)4015016-1 (DE-588)4076308-0 (DE-588)4203852-2 (DE-588)4138597-4 (DE-588)4143413-4 |
title | Drug injecting and HIV infection global dimensions and local responses |
title_auth | Drug injecting and HIV infection global dimensions and local responses |
title_exact_search | Drug injecting and HIV infection global dimensions and local responses |
title_full | Drug injecting and HIV infection global dimensions and local responses ed. by Gerry V. Stimson ... |
title_fullStr | Drug injecting and HIV infection global dimensions and local responses ed. by Gerry V. Stimson ... |
title_full_unstemmed | Drug injecting and HIV infection global dimensions and local responses ed. by Gerry V. Stimson ... |
title_short | Drug injecting and HIV infection |
title_sort | drug injecting and hiv infection global dimensions and local responses |
title_sub | global dimensions and local responses |
topic | Infections à VIH - transmission Toxicomanie intraveineuse Échange aiguille AIDS (Disease) Prevention HIV Infections prevention & control HIV Infections transmission Intravenous drug abuse Needle Sharing adverse effects Substance Abuse, Intravenous complications Substance Abuse, Intravenous prevention & control Epidemiologie (DE-588)4015016-1 gnd Prävention (DE-588)4076308-0 gnd HIV-Infektion (DE-588)4203852-2 gnd Drogenabhängigkeit (DE-588)4138597-4 gnd |
topic_facet | Infections à VIH - transmission Toxicomanie intraveineuse Échange aiguille AIDS (Disease) Prevention HIV Infections prevention & control HIV Infections transmission Intravenous drug abuse Needle Sharing adverse effects Substance Abuse, Intravenous complications Substance Abuse, Intravenous prevention & control Epidemiologie Prävention HIV-Infektion Drogenabhängigkeit Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008509925&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT stimsongerryv druginjectingandhivinfectionglobaldimensionsandlocalresponses |